R&D
Why are eCOA studies still so challenging?
Although eCOA has been in clinical trials for decades, we continue to hit the same road blocks during operational set-up and implementation.
Digital
Sponsored
12 Questions with Sam Dixey
Find out more about Sam Dixey, Head of Medical Affairs Innovation and Technology (MAIT) at LUCENT Biopharma.
Market Access
A dynamic moment for pharma pricing: Insights from PPIC
At PPIC in Basel, pharma pricing experts discussed how policy changes and AI advances are altering the dynamics of pharmaceutical pricing and access.
Digital
Changing Faces: Digital and supplier hires, May 2026
The digital, supplier, CRO, and medtech services sectors continued to see a steady flow of leadership changes during the month of May.
R&D
Separating scientific risk assessment & consumer perception
In pharmaceutical development, conclusions are built on structured laboratory investigations and reproducible data, rather than simple classification.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
